Inventor · disambiguated record
David Erick Wright
Also filed as: WRIGHT DAVID · WRIGHT DAVID E · WRIGHT DAVID ERICK
16 granted patents·8 pending applications·136 citations·filing 1985–2024
93Inventor score
Files withMYELOS CORP7HORIZON THERAPEUTICS USA INC5WRIGHT DAVID E3HORIZON PHARMA RHEUMATOLOGY LLC2MCNEILAB INC2
Top patents by PatentIndex Score
24 records- 0196US11639927B2Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapyHORIZON THERAPEUTICS USA INC·Filed 2020·Granted May 2, 2023·7 cites·9 claims
- 0296US11598767B2Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapyHORIZON THERAPEUTICS USA INC·Filed 2022·Granted Mar 7, 2023·5 cites·4 claims
- 0395US10823727B2Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapyHORIZON PHARMA RHEUMATOLOGY LLC·Filed 2018·Granted Nov 3, 2020·12 cites·3 claims
- 0495US10139399B2Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapyHORIZON PHARMA RHEUMATOLOGY LLC·Filed 2018·Granted Nov 27, 2018·11 cites·6 claims
- 0594US9377454B2Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapyROSARIO-JANSEN THERESA·Filed 2010·Granted Jun 28, 2016·33 cites·6 claims
- 0691US2025231181A1Methods and kits for predicting infusion reaction risk and antibody mediated loss of response by monitoring serum uric acid during pegylated uricase therapyHORIZON THERAPEUTICS USA INC·Filed 2024·Application pending·0 cites
- 0790US12188927B2Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapyHORIZON THERAPEUTICS USA INC·Filed 2024·Granted Jan 7, 2025·0 cites·17 claims
- 0885US11982670B2Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapyHORIZON THERAPEUTICS USA INC·Filed 2023·Granted May 14, 2024·0 cites·9 claims
- 0977US7115571B1Retro-inverso peptides derived from interleukin-3MYELOS CORP·Filed 2000·Granted Oct 3, 2006·9 cites·9 claims
- 1076US7754688B2Methods of using retro-inverso peptides derived from interleukin-6MYELOS CORP·Filed 2006·Granted Jul 13, 2010·2 cites·8 claims
- 1171US7135461B1Retro-inverso peptides derived from interleukin-6MYELOS CORP·Filed 2000·Granted Nov 14, 2006·4 cites·9 claims
- 1270US7109168B1Retro-inverso peptides derived from leukemia inhibitory factorMYELOS CORP·Filed 2000·Granted Sep 19, 2006·2 cites·9 claims
- 1365US7754690B2Method of using retro inverso peptides derived from leukemia inhibitory factorMYELOS CORP·Filed 2006·Granted Jul 13, 2010·0 cites·7 claims
- 1465US4742156APeptide antagonists of neurokinin B and opthalmic solutions containing themMCNEILAB INC·Filed 1986·Granted May 3, 1988·29 cites·10 claims
- 1563US4665157APeptide antagonists of neurokinin BMCNEILAB INC·Filed 1985·Granted May 12, 1987·10 cites·5 claims
- 1663US2016377604A1Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapyCREALTA PHARMACEUTICALS LLC·Filed 2016·Application pending·0 cites
- 1756US6458357B1Retro-inverso neurotrophic and analgesic peptidesMYELOS CORP·Filed 1998·Granted Oct 1, 2002·12 cites·28 claims
- 1856US2024085416A1Use of microvirin in the identification of mycobacterium tuberculosis mannose-capped lipoarabinomannanUNIV VANDERBILT·Filed 2021·Application pending·0 cites
- 1951US2008159976A1Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricaseHARTMAN JACOB·Filed 2007·Application pending·0 cites
- 2049US2007054854A1Methods of using retro-inverso peptides derived from interleukin-3WRIGHT DAVID E·Filed 2006·Application pending·0 cites
- 2149US2012172305A1Retro-inverso peptides derived from interleukin-6WRIGHT DAVID E·Filed 2011·Application pending·0 cites
- 2248US8063016B2Retro-inverso peptides derived from interleukin-6WRIGHT DAVID E·Filed 2010·Granted Nov 22, 2011·0 cites·6 claims
- 2347US2011190213A1Retro-inverso peptides derived from interleukin-3MYELOS CORP·Filed 2010·Application pending·0 cites
- 2436US2002128193A1Retro-inverso prosaposin-derived peptides and use thereofFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Erick Wright files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →